The Cannabis Industry’s take on the Hemp Industry
A discussion with the National Cannabis Industry Association’s Committee leaders on novel, synthetic, and minor cannabinoids.





Christopher Hope - Sequoia Management Group
Darwin Millard - ASTM International
James Granger - Cliintel Capital Group
Rhiannon Woo - TraceTrust
Stanley Atkins II - Minorities for Medical Marijuana
Darwin Millard - ASTM International
James Granger - Cliintel Capital Group
Rhiannon Woo - TraceTrust
Stanley Atkins II - Minorities for Medical Marijuana
Wednesday, March 29, 2023
3:35 PM - 4:20 PM
Advocacy & Policy Conference
Breakout Stage